BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 12, 2006
View Archived Issues
Snapshots on the antineoplastic effects of farnesyltransferase inhibitors
Read More
Degarelix achieves positive phase IIb results, enters phase III development
Read More
CRx-119 misses endpoint in exploratory immunoinflammatory disease model
Read More
EvoGenix inlicenses anticancer antibody
Read More
Genelabs draws up protocol for additional Prestara trial
Read More
New phase II study begins for GLP-1 agonist AVE-0010
Read More
Praecis enters pilot study and option agreement with GSK
Read More
Forest and Almirall sign U.S. agreement for COPD treatment LAS-34273
Read More
Enrollment terminated in GENASIS trial
Read More
Adventrx and SD Pharmaceuticals sign definitive merger agreement
Read More
Pharmacyclics acquires therapeutic programs from Celera Genomics
Read More
Quigley to begin clinical studies for QR-333
Read More
Pharmos awarded Israeli grant for CB2-selective drug development
Read More
BL-1020 for schizophrenia studied in phase I trial
Read More
Rufinamide efficacy revealed in partial seizures
Read More
Indiplon improves insomnia
Read More
Studies evaluate FTY-720 in humans, investigate mechanism of action
Read More
Analyses show noninferiority of faropenem antibiotic efficacy
Read More
Resistant pneumococcal disease declined after introduction of conjugate vaccine
Read More
Bivalent human papillomavirus vaccine provides long-term protection
Read More
NXL-101 evaluated in phase I study
Read More
Silenor gives statistically significant improvements in wake after sleep onset
Read More
Ambrisentan improves exercise capacity in PAH patients
Read More
Supplemental BLA submitted for Avastin in NSCLC
Read More
Novel 5-HT6 agonists from Wyeth presented at ACS
Read More
S1P receptor agonists emerge from Praecis R&D
Read More
New treatment strategies for cancer covered in recent patents
Read More
Indena synthesizes water-soluble camptothecin analogue with promising profile
Read More
Chiron presents preclinical data on its selective Raf kinase inhibitor CHIR-265
Read More
